nodes	percent_of_prediction	percent_of_DWPC	metapath
Methsuximide—Pethidine—SLC6A3—Gilles de la Tourette syndrome	0.252	1	CrCbGaD
Methsuximide—CACNA1I—brain—Gilles de la Tourette syndrome	0.167	0.223	CbGeAlD
Methsuximide—CACNA1G—nervous system—Gilles de la Tourette syndrome	0.15	0.2	CbGeAlD
Methsuximide—CACNA1G—central nervous system—Gilles de la Tourette syndrome	0.144	0.193	CbGeAlD
Methsuximide—CACNA1G—brain—Gilles de la Tourette syndrome	0.114	0.153	CbGeAlD
Methsuximide—CACNA1H—nervous system—Gilles de la Tourette syndrome	0.0979	0.131	CbGeAlD
Methsuximide—CACNA1H—brain—Gilles de la Tourette syndrome	0.0748	0.1	CbGeAlD
